Bellerophon Therapeutics, Inc. , a clinical-stage biotherapeutics company, today announced the appointments of Amit Agrawal as Chief Operating Officer, effective July 8, 2015, and Naseem Amin, M.D. as an Independent Director of the Company, effective June 29, 2015. Mr. Agrawal joins Bellerophon from Amgen, Inc., where, since 2012, he served as Director of Strategy and Corporate Development.